Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
University of Calgary · Hotchkiss Brain Institute · +76 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
119
total citations
- FWCI
- 41.64
- Percentile
- 100%
- References
- 29
Citations per year
Authors
750- SBShelagh B. CouttsCorresponding
University of Calgary, Hotchkiss Brain Institute
- SASandeep Ankolekar
King's College Hospital
- RARamana Appireddy
Queen's University
- JFJuan F. Arenillas
Universidad de Valladolid, Hospital Clínico Universitario de Valladolid
- ZAZarina Assis
Alberta Children's Hospital, Foothills Medical Centre
Topics & keywords
Topics
Keywords
- Tenecteplase
- Medicine
- Thrombolysis
- Ischaemic stroke
- Stroke (engine)
- Occlusion
- Population
- Fibrinolytic agent
No related works found for this paper.